| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Revenue | $9.9M | -41.0% |
| Cost of Revenue | $7.1M | -42.1% |
| Gross Profit | $2.8M | -38.0% |
| R&D Expense | $65K | -92.4% |
| SG&A Expense | $22.7M | -47.6% |
| Operating Income | -$22.0M | +57.7% |
| Pre-tax Income | -$25.3M | +51.2% |
| Net Income | -$71.2M | -37.4% |
| EPS (Basic) | -$6.36 |
| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $202K | -85.8% |
| Accounts Receivable | $400K | -69.8% |
| Inventory | $3.2M | -61.0% |
| Current Assets | $5.0M | -61.1% |
| Total Assets | $7.1M | -90.5% |
| Current Liabilities | $23.8M | -39.0% |
| Total Liabilities | $25.7M | -39.3% |
| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.4M | +44.5% |
| Investing Cash Flow | -$1.6M | +0.0% |
| Financing Cash Flow | $5.8M | -57.6% |
| +52.7% |
| EPS (Diluted) | -$6.36 | +52.7% |
| Stockholders' Equity |
| -$18.6M |
| -157.3% |